Mycobacterium tuberculosis Detection, Nucleic Acid Amplification (NAA)
| Mycobacterium tuberculosis Detection, Nucleic Acid Amplification (NAA) | | | |
| Number | | 550087 |
| CPT | | 87556 |
| Synonyms | | TB Stat Test |
| Specimen | | Sputum, respiratory aspirate, lavage fluid, pleural fluid, cerebrospinal fluid, or respiratory tissue |
| Volume | | 5 mL, 1 mL cerebrospinal fluid (CSF), or a small piece of respiratory tissue (2 mL from needle biopsy) |
| Container | | Sterile screw-cap container; seal cap tightly. |
| Collection | | If the specimen is to be split for additional testing, it should be divided so that each portion is transported at the appropriate temperature. |
| Storage Instructions | | Refrigerate |
| Patient Preparation | | When collecting sputum, have the patient brush teeth or remove dentures and rinse mouth with water. Instruct the patient not to collect saliva. When collecting aspirates, use standard aseptic preparation. Respiratory tissue specimens may be fresh or frozen. |
| Causes for Rejection | | Inappropriate specimen transport device; unlabeled specimen or name discrepancy between specimen and request label; specimen received after prolonged delay (usually more than 72 hours). Blood and bone marrow are not suitable for amplification test. Tissue not of respiratory origin will not be tested. |
| Use | | Detect and identify Mycobacterium tuberculosis in sputum and respiratory specimen |
| Limitations | | This procedure may be considered by Medicare and other carriers as investigational and, therefore, may not be payable as a covered benefit for patients. |
| Methodology | | Nucleic acid amplification (NAA) technology, such as polymerase chain reaction, transcription mediate amplification, or strand displacement amplification |
|